This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Kymab Limited. Active years: 2016-2023.
Company Filing History:
Years Active: 2016-2023
Title: Victor Tkachev: Innovator in Antibody Research
Introduction
Victor Tkachev is a prominent inventor based in Seattle, WA. He has made significant contributions to the field of antibody research, holding a total of 2 patents. His work focuses on innovative therapeutic methods that address autoimmune and alloimmune diseases.
Latest Patents
Tkachev's latest patents include groundbreaking inventions related to antibodies and their applications. One of his notable patents is centered on "Antibodies, combinations comprising antibodies, biomarkers, uses and methods." This invention pertains to combinations that include anti-human OX40L antibodies, new biomarkers for autoimmune or alloimmune diseases, and their therapeutic uses. Another significant patent is titled "Anti-human OX40L antibodies and methods of treating graft versus host disease with the same." This invention discusses anti-human OX40L antibodies and their new medical applications and methods.
Career Highlights
Victor Tkachev is currently associated with Kymab Limited, where he continues to advance his research in antibody therapies. His work has the potential to impact the treatment of various medical conditions significantly.
Collaborations
Tkachev has collaborated with notable professionals in his field, including Philip Bland-Ward and Leslie Susan Kean. These collaborations have further enriched his research and innovation efforts.
Conclusion
Victor Tkachev is a key figure in the field of antibody research, with a focus on developing innovative therapeutic methods. His contributions through patents and collaborations highlight his commitment to advancing medical science.